Opinion

Simmons v. Secretary of Health and Human Services

Court
United States Court of Federal Claims
Filed
Apr 8, 2019
Status
Unpublished
On the bench
Laura D. Millman
Cited by
0 cases
Authority
More cited than 7.4%

The opinion

In the United States Court of Federal Claims

OFFICE OF SPECIAL MASTERS

No. 11-216V

Filed: March 14, 2019

Not to be Published

*************************************

JEFFREY DAVID SIMMONS, *

*

Petitioner, * Petitioner’s Motion for a Ruling on

* Damages Award

*

v. *

*

SECRETARY OF HEALTH *

AND HUMAN SERVICES, *

*

Respondent. *

*

*************************************

Clifford J. Shoemaker, Vienna, VA, for petitioner.

Justine E. Walters, Washington, DC, for respondent.

MILLMAN, Special Master

RULING ON DAMAGES AWARD1

On April 7, 2011, petitioner filed a petition under the National Childhood Vaccine Injury

Act, 42 U.S.C. § 300aa-10-34 (2012), alleging that the tetanus toxoid-diphtheria-acellular

pertussis (“Tdap”) vaccine he received on April 11, 2008 caused him anaphylaxis, immune

dysregulation, and autoimmune disease leading to Addison’s disease. Pet. at ¶ 107. Petitioner

was 38 years old when he received Tdap vaccine. He is now 49 years old.

On October 30, 2015, the undersigned ruled that petitioner is entitled to compensation,

holding “. . . it is reasonable to connect petitioner’s entire immunologic reaction to his adverse

response [to the Tdap vaccine]. . . . [P]etitioners do not have the burden of proving a specific

1

Because this unpublished ruling contains a reasoned explanation for the action in this case, the

undersigned intends to post it on the United States Court of Federal Claims' website, in accordance with

the E-Government Act of 2002. 44 U.S.C. § 3501 note (2012) (Federal Management and Promotion of

Electronic Government Services). This means the ruling will be available to anyone with access to

the Internet. In accordance with Vaccine Rule 18(b), petitioner has 14 days to identify and move to

redact medical or other information, the disclosure of which would constitute an unwarranted invasion of

privacy. If, upon review, the undersigned agrees that the identified material fits within this definition,

the undersigned will redact such material from public access.

biological mechanism.” Simmons v. Sec’y of HHS, No. 11-216V, 2015 WL 6778563, at *8

(Fed. Cl. Spec. Mstr. Oct. 30, 2015). Since then, the parties have been engaged in resolution of

damages. Both parties have filed life care plans but have failed to settle damages.

One barrier to settlement is the calculation of petitioner’s lost wages. On July 19, 2016,

petitioner’s economist Dr. Robert W. Cook submitted his first expert report stating petitioner’s

net lost income is $4,950,921.00. Doc 113-2.

On May 23, 2017, respondent filed his first expert report from his economist Dr. Patrick

F. Kennedy stating petitioner has $1,017,816.00 in loss of earnings and benefits. Doc 143-1.

During a status conference held on June 5, 2017, the undersigned gave petitioner until June 30,

2017 to file Dr. Cook’s responsive report.

On September 20, 2017, petitioner filed the first affidavit of Mr. Jeff Barrom, a Senior

Vice President with Hub International Northwest, LLC (“HUB International”). Doc 148-2.

On October 30, 2017, after three motions for an extension of time, petitioner filed Dr.

Cook’s supplemental (second) expert report based on information provided in Mr. Barrom’s first

affidavit, concluding petitioner has $3,978,303.00 in net lost income. Doc 150-2.

During a status conference held on November 17, 2017, the undersigned discussed the

parties’ expert reports (Docs 113-2, 143-1, and 150-2) and Mr. Barrom’s affidavit (Doc 148-2).

On November 20, 2017, the undersigned issued an order addressing several issues in the parties’

economic expert reports, and requiring Mr. Barrom to answer respondent’s additional questions

and each party to file their supplemental economist reports. Doc 151. In the same Order, the

undersigned required the parties’ experts, in their supplemental expert reports, to use: (1) the

same date, January 1, 2018,2 as the demarcation between petitioner’s past and future damages,

subject to future changes; (2) the same lengths of life expectancy (March 8, 2049) and work life

expectancy (May 28, 2033); (3) $42,070.00 as the base W-2 income in 2009 to calculate

petitioner’s incomes from 2010 to at least March 31, 2014; and (4) Employment and Earnings for

Insurance Agencies and Brokerages (“EEIAB”) as the source for projections of petitioner’s wage

growth since the data are specific to the insurance industry. Id. at 2-3.

On January 25, 2018, petitioner filed Mr. Barrom’s second affidavit, in which Mr.

Barrom said he cannot provide copies of the material upon which he relied because the material

is “confidential and proprietary.” Doc 153-2, at 1.

On April 10, 2018, petitioner filed Dr. Cook’s supplemental (third) expert report

providing petitioner’s lost wages as “no less than $2,619,329.00 and no more than

$3,698,921.00.” Doc 159-2, at 9. On April 16, 2018, respondent filed Dr. Kennedy’s

supplemental (second) expert report in response to the undersigned’s Order of November 20,

2017 and to Mr. Barrom’s second affidavit. Doc 160-1.

2

Considering the failure of the parties to settle, the demarcation between past and future damages shall now be the

date of this Ruling and not January 1, 2018.

2

In an email on April 27, 2018 to the undersigned’s law clerk, respondent stated if

petitioner intended to continue to rely on Mr. Barrom’s affidavits, he should produce the material

upon which Mr. Barrom relied in his statements supporting petitioner’s loss of earnings. On

April 27, 2018, petitioner filed a status report asserting that the record on lost wages was

complete and Mr. Barrom would not be able to provide copies of documentation upon which he

relied in his affidavits due to confidentiality and proprietary issues. Doc 161, at 1.

On April 30, 2018, the undersigned issued an order requiring respondent to file a Motion

for Discovery of the material upon which Mr. Barrom relied in his affidavits. On May 21, 2018,

respondent filed a Motion for Production of Documents Regarding Petitioner’s Lost Wages

Claim (“Motion for Production”).

On May 22, 2018, petitioner filed a Notice of Clarification and Partial Response to

Motion to Produce Documents stating that because petitioner is not in possession of the

documents and has no ownership of the documents, respondent should be seeking Third Party

Discovery as neither Mr. Barrom nor HUB International is a party in this case. Doc 165, at 1.

On June 5, 2018, respondent filed a response to Petitioner’s Notice of Clarification and

Response to Motion to Produce Documents stating that it is petitioner’s burden to prove

petitioner’s damages and “a special master cannot award over $1 million in additional lost wages

based on a third party’s interpretation of undisclosed evidence that neither party nor the Court

has seen.” Doc 167, at 2.

On the same day, the undersigned ordered each party to select by June 19, 2018 one of

three options: (1) the undersigned will hold a hearing on economic loss with Dr. Cook, Dr.

Kennedy, and Mr. Barrom as witnesses; (2) petitioner shall serve a subpoena duces tecum on

HUB International to produce the documents upon which Mr. Barrom relied in his affidavits; or

(3) the undersigned will decide the issue of lost wages on motion for a Ruling on the Record.

On June 19, 2018, after respondent filed a status report choosing option (2), petitioner

filed a status report requesting 30 days to provide the updated life care plan costs and a Motion

for Ruling on the Record incorporating all elements of compensation. The undersigned granted

petitioner’s informal motion and ordered petitioner to file a Motion for Ruling on the Record

incorporating all elements of compensation by July 18, 2018. The undersigned denied

respondent’s Motion for Production as moot.

On July 17, 2018, petitioner filed an updated summary chart of all past unreimbursable

medical expenses (Docs 173-2 and -3) and petitioner’s updated life care plan (Doc 173-4) with

an analysis of cost differences between his plan (Docs 128-2 and 173-4) and respondent’s plan

(Doc 136-6). On July 18, 2018, petitioner filed his Medicaid Lien update and a press release

regarding Mr. Barrom.

On July 18, 2018, petitioner filed a Motion for [a] Ruling on Damages Award

3

(“motion”).

On August 29, 2018, the case was referred to another special master for a mandatory

settlement conference.3 By email contact with the undersigned’s law clerk and the mediator’s

law clerk, the parties on two occasions expressed a wish not to participate in mediation but to

have the undersigned rule on the record. This ruling is a response to the parties’ wishes and, by

separate order, the undersigned removed this case from mediation.

On October 26, 2018, respondent filed a response to petitioner’s motion (“response”).

On November 2, 2018, petitioner filed a reply to respondent’s response to petitioner’s

motion (“reply”).

On November 20, 2018, petitioner filed Exhibit 91 consisting of a final Medicaid lien

amount of $465.36. On the same date, petitioner filed a status report stating that there were no

outstanding items left for petitioner to file and the case was ripe for the undersigned’s decision

on damages.

On December 11, 2018, the undersigned issued a Ruling on Damages. On December 17,

2018, petitioner filed a Motion for Reconsideration, requesting the undersigned include the

updated past cost of life insurance premiums ($6,765.21) as part of the total of updated past

expenses in the damages award. Although on December 18, 2018, the undersigned denied

petitioner’s Motion for Reconsideration, on December 19, 2018, the undersigned withdrew the

denial of petitioner’s Motion for Reconsideration and issued an Order granting the Motion for

Reconsideration.

On March 5, 2019, respondent filed a Response to Ruling on Damages Award, requesting

the undersigned give respondent the opportunity to reply to petitioner’s Motion for

Reconsideration and withdrawing the December 11, 2018 Ruling on Damages to reissue the

Ruling on Damages with a complete listing of specific parameters. The undersigned held a

telephonic status conference with the parties on March 13, 2019 to clarify these requests.

On March 13, 2019, the undersigned issued an Order withdrawing the December 19,

2018 Order granting petitioner’s Motion for Reconsideration and withdrawing the undersigned’s

December 11, 2018 Ruling on Damages which included $25,499.50 in past unreimbursable

medical expenses (which award was the subject of petitioner’s Motion for Reconsideration).

This more specific Ruling on Damages does not include any past unreimbursable medical

expenses because the undersigned is waiting until April 15, 2019 for respondent to respond to

petitioner’s Motion for Reconsideration whether to include the $6,765.21 cost for health

insurance premiums to the amount of $25,499.50 which would then bring the total award for past

unreimbursable medical expenses to $32,264.71.

3

The Office of Special Masters had implemented a mandatory settlement program for certain non-autism

cases filed in 2012 or beforehand.

4

After respondent files his response to petitioner’s Motion for Reconsideration on the

issue of past unreimbursable medical expenses on April 15, 2019, petitioner has two days until

April 17, 2019 to file a reply.

In addition, respondent shall file a report by April 15, 2019, updating the figures for

wage loss and other items from respondent’s prior filings, including net present value and growth

rates for appropriate items. The demarcation date for past and future damages is the date of this

Order, March 14, 2019.

After petitioner files a reply to respondent’s response to petitioner’s Motion for

Reconsideration, the undersigned will issue a Damages Decision including the updated figures

reflecting net present value and growth rate, and the amount of past unreimbursable medical

expenses.

MOTION AND FILINGS

On July 18, 2018, petitioner filed his Motion for [a] Ruling on Damages Award.

Petitioner updated his calculation of economic loss to $4,480,530.62, consisting of wage loss of

$3,698,921.00, life care plan costs of $753,837.00, unreimbursable medical expenses of

$25,499.50, and Medicaid Lien of $2,173.12, and asserted that he is entitled to the full

$250,000.00 in pain & suffering. Doc 176.

On October 26, 2018, respondent filed his response rejecting the amount of each damage

component requested in petitioner’s motion arguing: (1) because petitioner relies upon Mr.

Barrom’s affidavits in the absence of corroborating evidence needed to support his valuation of

lost wages, respondent requested the undersigned award lost earnings in accordance with

respondent’s economist Dr. Kennedy’s analysis and projections, which is $1,019,102.00 (Doc

160-2, at 1); (2) because a petitioner cannot recover damages for a non-identified autoimmune

disease (referring to the Vaccine Act without a citation and citing Broekelschen v. Sec’y of HHS,

618 F.3d 1339 (Fed. Cir. 2010)) and Dr. Weiss4 is the only expert respondent says is qualified to

opine on petitioner’s proper treatment in this case, petitioner’s past unreimbursable medical

expenses and life care plan costs should be reduced to include adrenal insufficiency, petitioner’s

only “defined and recognized injury”; (3) the undersigned should not compensate petitioner

Medicaid Lien since he has not provided an itemized list of the services paid for by Medicaid on

his behalf; and (4) petitioner is not entitled to the maximum award of $250,000.00 for actual pain

and suffering, but respondent defers to the undersigned’s discretion. Doc 184, at 5-15.

On November 2, 2018, petitioner filed his reply to respondent’s response. Petitioner

4

On November 13, 2016, one year and two weeks after the undersigned issued a Ruling on Entitlement in

favor of petitioner, respondent filed an expert report of Dr. Roy E. Weiss, an endocrinologist, as Exhibit

M. Dr. Weiss states there is no evidence in this case that petitioner has Addison’s disease. Id. at 1. Dr.

Weiss then criticizes the costs for medications, blood tests, care givers, and transportation petitioner’s life

care planner included in the life care plan.

5

argues: (1) petitioner has produced substantial underlying documentation of his lost wages

demand with three economist reports from his expert Dr. Cook and two affidavits from a fact

witness Mr. Barrom who has provided answers to all of respondent’s and the undersigned’s

questions; (2) respondent’s reliance on Broekelschen is misplaced and the undersigned made it

clear in her ruling on entitlement that petitioner does not have full-blown Addison’s disease;

therefore, petitioner is entitled to compensation for his past unreimbursable medical expenses

and life care plan costs in full; (3) petitioner is entitled to the full $250,000.00 in pain and

suffering since his suffering has already exceeded the statutory cap based on his wife’s

testimony; and (4) petitioner will provide the final Medicaid Lien as soon as possible. Doc 186,

at 1-6.

DISCUSSION

I. Lost Wages

For calculating petitioner’s lost earnings award, petitioner’s expert Dr. Cook projects the

following five categories of income into the future:

(a) Petitioner’s expected base salary as an employee of Argus Insurance Inc. (“Argus”);

(b) Petitioner’s expected K-1 income as part owner of Argus;

(c) Petitioner’s W-2 income as the result of the transfer of retiring agent accounts;

(d) Employer contributions to petitioner’s 401(k) account; and

(e) The sale value at retirement of petitioner’s ownership interest in Argus.

Doc 159, at 3.

On the other hand, respondent’s expert Dr. Kennedy believes that the only component

that should be included in the calculation is petitioner’s W-2 base salary and commissions (“W-2

income”). In his first expert report, Dr. Kennedy analyzes petitioner’s K-1 income for

illustrative purposes only. Doc 143-1, at 5. Because petitioner’s affidavit and a 2009 K-1 were

the only support at that time for petitioner’s loss of annual K-1 income from January 1, 2009 to

April 1, 2014 when Argus was sold to HUB International, Dr. Kennedy argues that he “cannot

opine that it is more likely than not that the 2009 K-1 income would have continued at the same

level in all future years.” Id. at 4.

On September 20, 2017 and January 24, 2018, petitioner filed Mr. Barrom’s two

affidavits, both of which support petitioner’s K-1 income calculation. However, Dr. Kennedy

maintains in his second expert report that no supporting documentation has been produced that

could be used to verify that petitioner’s statements and calculations for his loss of K-1 income

are accurate. Doc 160-1, at 3. For the same reason, Dr. Kennedy disagrees with including

petitioner’s retiring producer W-2 income in the calculation of petitioner’s past and future loss of

earnings. Id. at 5.

6

In addition, the parties disagree on the present value methodology. While Dr. Cook uses

a two-step discounting approach, Dr. Kennedy uses a one-step net discount rate (“NDR”)

approach.

Thus, the main disagreements between the parties are: (1) whether Mr. Barrom’s

affidavits in the absence of part or all corroborating evidence are sufficient to support petitioner’s

valuation of the disputed components of his lost earnings, which include W-2 income, ownership

income,5 and retiring producer W-2 income; and (2) the method in the calculation of the present

value of petitioner’s future wage loss.

A. W-2 Income

In his first expert report, Dr. Cook takes petitioner’s base W-2 income in 2009 as

$42,000.00 and projects it into the future with the wage growth rates based on Board of Trustees

– Federal Old-Age and Survivors Insurance and Disability Insurance Trust Funds (“OASDI”).

Doc 113-2, at 11. The sum of petitioner’s W-2 income was $1,450,731.00.

In his first expert report, Dr. Kennedy uses the base W-2 income in 2009 as $42,070.00

and projects it into the future with the wage growth rates based on EEIAB, which the

undersigned ruled as the preferable basis in her Order of November 20, 2017. Doc 143-1, at 3.

The sum of petitioner’s W-2 income was $1,017,816.

In his second expert report, Dr. Cook raises the base W-2 income starting in 2010 from

$43,100.00 to $112,500.00, relying solely on Mr. Barrom’s answer to Question 6 in his first

affidavit, resulting in an increase in the sum of petitioner’s W-2 income from $1,450,731.00 in

Dr. Cook’s first report to $3,086,441.00. Doc 150-2, at 2-3. The undersigned identified this

issue in her Order of November 20, 2017:

Question 6 in Mr. Barrom’s affidavit, dated September 20, 2017, reads “Jeff’s

HUB/Argus Income 2014-today? Rather, from what income would Jeff’s

share have been calculated? If prefer to simply state what Jeff’s income would

have been today.” According to Mr. Barrom’s Answer 6, the annual income

of an insurance agent on the same track as petitioner was would be, if all

production goals were met, between $100,000.00 and $125,000.00. The

undersigned finds this answer is too vague for the parties’ experts to use as a

base annual salary from April 1, 2014, the time of sale of Argus to HUB.

While “2014-today (September 20, 2017)” is an over 3-year period of time,

Mr. Barrom did not specify in his answer what was the time period he

intended. Furthermore, no information explains why the base W-2 salary

before the sale of Argus ($42,070.00) and after (between $100,000.00 and

$125,000.00) would be so different if, as Mr. Barrom stated in his Answer 2,

“the model of compensation for agents [at HUB] is similar to what was in

5

Petitioner’s loss of ownership income includes both loss of K-1 income from January 1, 2010 to April 1,

2014 and the loss on the sale of Argus ownership interest in 2014. Doc 143-1, at 5.

7

place at Argus at the time of the sale.” Dr. Cook should not have in his

second report increased petitioner’s W-2 salary to $112,500 from 2010, over

three years before the sale of Argus.

Doc 151, at 2. The undersigned instructed Dr. Cook to change his calculation of annual income

to reflect these corrections. Id.

In his third expert report, Dr. Cook relies solely on Mr. Barrom’s answer to Question 4 in

his second affidavit to run petitioner’s W-2 income from 2010 to 2017 and then based on the

2017 W-2 income projection to calculate petitioner’s future wages from 2018 to 2033. While

Mr. Barrom stated in his first affidavit that “it is difficult to speculate exact incomes” and

provided the estimated annual earnings range for 2017 of $100,000.00 - $125,000.00 (Doc 148-

2, at 2), he provides in his second affidavit a spreadsheet showing an estimated 2010

compensation of $62,070.00 growing to an estimated $121,024.00 by 2017 without providing

any database or supporting documentation (Doc 153-2, at 2-3). Dr. Cook adopts Mr. Barrom’s

projections without providing any further explanation or analysis. The undersigned finds that

Mr. Barrom’s projections of petitioner’s W-2 income from 2010 to 2017 and Dr. Cook’s

adoption of Mr. Barrom’s projections in his third expert report are speculative and inconsistent

with petitioner’s historical earnings and the industry data.

In his second expert report, Dr. Kennedy states that “while the information provided by

Mr. Barrom appears to support some of [p]etitioner’s damages calculations, no supporting

documentation has been produced that could be used to verify that his statements and

calculations are accurate.” Doc 160-1, at 3. Because petitioner is claiming a level of wages

and wage growth that are materially higher than statistical earnings data for insurance agents in

general and are inconsistent with petitioner’s historical wage growth prior to vaccination, Dr.

Kennedy argues that it is important to understand how Mr. Barrom arrived at his projections and

what documentation or information upon he relied in making his projections. Id. at 4.

In her Order of June 5, 2018, the undersigned provided petitioner with an option of

serving a subpoena duces tecum on HUB International to produce the documents upon which

Mr. Barrom relied in his affidavits; however, petitioner chose to file a motion for ruling on the

record. The undersigned agrees with Dr. Kennedy that it is important for a damages expert to

verify the information that forms the basis of a loss calculation, especially when petitioner’s

claimed net losses of nearly $4 million are based on projected wages that are much higher than

his prior years’ earnings as well as the statistical earnings data for insurance agents as collected.

The undersigned finds that the underlying material upon which Mr. Barrom based his projections

is necessary for the undersigned to reach a fair and well-informed decision concerning

petitioner’s W-2 income. Therefore, in the absence of petitioner’s filing this material, the

undersigned rules in favor of respondent on the calculation of petitioner’s W-2 income.

B. Ownership Income

Effective January 1, 2009, petitioner purchased a 4.99% ownership interest in Argus and

8

executed a promissory note for the $550,310.48 purchase price payable to Argus. Petitioner

received $118,366.00 in business income via K-1 (“K-1 income” or “business income”) from

Argus in 2009. On April 1, 2014, HUB International acquired Argus and all holders of

promissory notes were required to pay them off with the proceeds from the sale to HUB

International. Doc 148-2, at 2. The sale price of Argus to HUB International is confidential.

Id. In his first affidavit, Mr. Barrom provided the exact amount of gross distributions from

petitioner’s 4.99% ownership shares for 2010 through 2014 in the absence of any supporting

documents. Id. at 1. In his second affidavit, Mr. Barrom stated that petitioner would have

received the full approximate gross distribution for 2014 regardless of the sale of Argus in April

2014. Doc 153-2, at 2.

In his second expert report, Dr. Cook agrees with Dr. Kennedy that the calculation for

petitioner’s K-1 income should not increase annually for the duration of petitioner’s work life

expectancy since January 1, 2010. Instead it should terminate on April 1, 2014 when HUB

International acquired Argus. Doc 150-2, at 3. In both his second and third expert reports, Dr.

Cook adopts the exact amount of gross distributions that Mr. Barrom provided, resulting in

$499,344.00 of petitioner’s lost K-1 income before tax for 2010 through 2014.

In his first expert report, for illustrative purposes only, Dr. Kennedy analyzes petitioner’s

lost business income from January 1, 2010 to April 2014, using petitioner’s annual K-1 income

of $118,366.00 for 2009 and adjusting the annual compensation at the wage growth rates based

on EEIAB. Doc 143-1, at 5. Petitioner’s potential lost K-1 income after tax is $432,123.00.

Doc 143-5, at 3. Dr. Kennedy then projects petitioner’s promissory note payments6 as an

offset to his potential damages and adds petitioner’s loss on sale of Argus ownership interest in

2014,7 resulting in a total of $338,859.00 as petitioner’s potential economic loss of his

ownership income after tax. In both his expert reports, Dr. Kennedy believes that a single K-1

for 2009 is not sufficient to determine petitioner’s loss of business income for 2010 through

April 2014. Doc 143-1, at 5 and Doc 160-1, at 1. Therefore, Dr. Kennedy does not include

petitioner’s potential economic loss of his ownership income in his calculation of petitioner’s

lost earnings award.

Because petitioner owned a 4.99% ownership interest in Argus, received a distribution in

2009, and provided his 2009 K-1, the undersigned finds an award for petitioner’s loss of

6

Petitioner took out a $550,310.48 loan to acquire Argus shares, effective January 1, 2009, with monthly

payments of $4,946.35 or $59,356.00 annually. Doc 143-5, at 3. Dr. Kennedy estimates that

petitioner’s payments ended upon the sale of Argus to HUB International in April 2014. Id.

7

Because the sale price of Argus to HUB International is confidential, Dr. Kennedy projected petitioner’s

loss on sale of Argus ownership interest in 2014 by applying a capitalization rate to net income as a

common valuation tool. “2009 K-1 income was $118,366.00. Restated to 2014 dollars, annual K-1

income is $138,777.00. K-1 Income / Capitalization Rate = Ownership Value ($138,777.00 / 24% =

$578,238.00).” Doc 143-1, at 5 n.4. From the $578,238.00 of Argus share value, Dr. Kennedy

deducted the remaining principal balance on the note payable for a net pre-tax amount of $165,143.00.

Id. at 5. In his second expert report, Dr. Cook agrees with Dr. Kennedy’s methodology. Doc 150-2, at

4.

9

ownership income reasonable in this case. However, because Mr. Barrom will not provide any

documentation to support his projections of petitioner’s business income for 2010 through 2014,

the calculation for petitioner’s loss of business income should be based on petitioner’s K-1

income of $118,366.00 for 2009 and the wage growth rates according to EEIAB. In other

words, the undersigned agrees with Dr. Kennedy’s calculation of petitioner’s potential lost

ownership income. Doc 143-5, at 1-4. Therefore, the undersigned rules that petitioner is

entitled to $338,859.00 as his loss of ownership income.

C. Retiring Producer W-2 Income

Unlike petitioner’s K-1 income, his claimed retiring producer income was not included in

petitioner’s 2009 tax documents. Petitioner claims that he was going to be compensated for

retiring producer income in 2010. Doc 131-2, at 2. In his first affidavit, Mr. Barrom stated that

“I no longer have records for such things but [petitioner] is honest and the retiring or transition

plan he submitted indicated payments in 2010, so yes he would have been paid the applicable

renewal commission that Argus used at that time, which would have been 25% had he met the

previous year new business goal and if not it would have been 20%.” Doc 148-2, at 3. Mr.

Barrom later confirmed that had petitioner been employed at Argus in 2010, he would have

received commission income for the retiring producer accounts that he had been working on in

2008 and 2009 and the retiring producer income would have been reported in his 2010 W-2.

Doc 153-2, at 3. According to Mr. Barrom’s affidavits, it takes one to three years for the

transitioning agent to receive income from retiring agent accounts. However, petitioner’s

evidence explaining how the commission on retiring producer accounts would be paid to the

retiring partner (“RP”) and the transitioning partner (“TP”) says otherwise:

Beginning with policies which have an effective date of 1/1/2009 and later,

RP will receive .20 points of the producer portion of the agency commission

with the TP receiving the remainder of the producer portion of the

commission.

Doc 113-3, at 7. This document shows that petitioner would have received income from the

retiring producer accounts in 2009.

While Mr. Barrom indicated in his first affidavit, Answer 9, that he no longer has records

to support additional transfers after 2010, he provided in his second affidavit exact amounts of

retiring producer income petitioner would have been paid for 2010 through 2014 without any

supporting evidence. Doc 153-2, at 4. In his third expert report, Dr. Cook adopts Mr.

Barrom’s projections without independently evaluating the underlying evidence and assumes that

this level of income would have continued through petitioner’s remaining work life expectancy.

Doc 159-2, at 12-13. As Dr. Kennedy points out in his second expert report, it is important to

see how much the retiring producer accounts that were to be assigned to petitioner actually

generated in commissions and how those accounts may have changed over time. Doc 160-1, at

5. The undersigned agrees with Dr. Kennedy’s opinion. There was no evidence that retiring

producer income was ever paid to petitioner in the manner described in the Argus policy

10

provided in petitioner’s evidence (Doc 113-3). Since the undersigned cannot award damages

based on speculation, she finds that petitioner is not entitled to the compensation for retiring

producer income.

D. Present Value Methodology

The parties disagree on the method of calculating the present value of petitioner’s future

wage loss. While Dr. Cook uses a two-step discounting approach, Dr. Kennedy uses a one-step

net discount rate (“NDR”) approach. The two-step discounting approach comprises two parts:

(1) future wages are grown annually at the appropriate rate for wage growth and (2) future values

are discounted to present day dollars at the appropriate projected interest rate. The NDR

approach incorporates both future wage growth and future interest rates into a single, one-step

calculation. Thus, if the same assumptions are used regarding interest rates and wage inflation,

the results under both approaches should be consistent.

Dr. Cook’s present value approach depends on the current yields on U.S. Treasury Notes

and Bonds, which are dynamic. Doc 159-2, at 6. Dr. Kennedy’s analysis implies a 3.50

percent annual wage growth and a 4.00 percent annual discount growth, which gives him a 0.50

percent fixed annual NDR. Doc 160-1 at 2. Dr. Cook argues that Dr. Kennedy’s reliance on a

fixed NDR is inappropriate since the interest rates available to petitioner are the same rates

available to all petitioners but the wage growth rate for all petitioners varies. Doc 159-2, at 7.

However, because the wage growth and interest rates are more difficult to project as

individual data series, Dr. Kennedy believes that “the net relationship between the two series is

more stable and can be more reliably projected over longer periods of time.” Doc 160-1, at 1-2.

The NDR approach also includes projected wage inflation. Id. at 2. Dr. Kennedy provides an

example in his second expert report to show that the NDR approach is more beneficial to

petitioner than the two-step discounting approach, if both approaches assume that the appropriate

wage inflation is 3.50 percent per year and the appropriate interest rate is 4.00 percent. Id. at 2-

3.

Thus, the disagreement between the parties is not which present value method is better

academically but what rates should be chosen in this case. The undersigned agrees with

respondent that Dr. Cook’s use of current dynamic interest rates alone as the discount rate is not

accurate for a projection of a future loss of earnings over a long period of years. The

undersigned finds it is reasonable for Dr. Kennedy not to rely too heavily on the recent historical

or current interest rates since it would result in an understated net discount rate and it is

appropriate to examine statistics over a longer period in calculating the NDR because a longer

period includes the series of expansions and recessions that the economy has experienced. Doc

143-1, at 9. The undersigned also thinks it is important to take consumer price inflation into

account over a long period of time as Dr. Kennedy does in his analysis. Id. at 8. Therefore, the

undersigned rules in favor of respondent on the issue of present value methodology.

II. Life Care Plans

11

On September 28, 2016, petitioner filed his original life care plan from his life care

planner Ms. Lynn Trautwein. Doc 128. Subsequently, respondent filed a report from Dr. Roy

Weiss rejecting all care items in petitioner’s life care plan indicated for Addison’s disease since

respondent asserts through Dr. Weiss’s post-entitlement ruling report that petitioner did not have

Addison’s disease. Doc 136-1, at 2-3. Respondent’s life care planner Ms. Linda Curtis relied

upon Dr. Weiss’ report to deny a substantial part of petitioner’s life care plan. Doc 183-1.

Petitioner argues in his motion that Dr. Weiss’ report was unnecessary as the undersigned

and the parties were well aware of the nature of petitioner’s diagnoses. Doc 176, at 6. In his

response, respondent claims that Dr. Weiss, as a board-certified endocrinologist, is the only

expert qualified to opine on the proper treatment of petitioner, and petitioner’s life care plan

should be based on the diagnosis of adrenal insufficiency, petitioner’s only defined and

recognized injury in this case. Doc 184, at 13.

The undersigned finds respondent’s argument against petitioner’s entitlement to

compensation for his entire immunologic reaction is contrary to law. The undersigned made it

clear in her ruling on entitlement that petitioner does not have full-blown Addison’s disease,

which is why petitioner’s treating doctor, Dr. Richard Wilkinson, diagnosed him with adrenal

insufficiency. Simmons v. Sec’y of HHS, No. 11-216V, 2015 WL 6778563, at *8 (Fed. Cl.

Spec. Mstr. Oct. 30, 2015). Respondent’s expert Dr. Levinson believed petitioner had an

adverse reaction to Tdap, but he did not know the mechanism involved and labeled petitioner’s

adverse reaction a hypersensitivity reaction, which the undersigned accepted in her ruling on

entitlement. Id. at *7-8. The undersigned held that a blurring of the distinctions among the

categories of adverse reaction does not preclude a finding of entitlement to damages. Id. at *8.

Therefore, the undersigned finds petitioner is entitled to compensation for his entire

immunologic reaction which Tdap vaccine caused.

The undersigned finds reasonable and necessary and awards the following:

The undersigned will pay for Washington Health Plan Finder Kaiser Permanente (KP)

VisitsPlus Silver HD, which in 2018 cost $6,897.72 annually now through 2034 when petitioner

becomes 65. This cost will have to be updated to 2019 rates. The undersigned does not find

awarding a $1,700 deductible necessary because petitioner would have a deductible under an

employer-sponsored health plan.

The undersigned will pay for Medicare Part D: SilverScript Choice (S5601-060-0)

Premium $579.99 annually from 2034 to life expectancy. This cost will have to be updated to

2019 rates. The undersigned does not find awarding the higher cost Medicap provider petitioner

recommended because it includes Medicare Part B which is an option to all Medicare Part A

recipients.

12

The undersigned will pay for visits to Dr. Wilkins twice a year until August 2034. The

yearly cost of $330.00 will have to be updated to 2019 rates. The undersigned assumes Kaiser

HMO would not pay for this cost.

The undersigned will pay for visits to Dr. Paul Emmons III, PCP two times a year, at

$223.60 annually through July 2033; then $44.72 annually from August 2034 to life expectancy.

This cost will have to be updated to 2019 rates. The undersigned assumes Kaiser HMO would

not pay for this cost.

The undersigned will pay for a visit to Bastyr University Medical Center to see an

immunologist once a year at a cost of $250.00 annually through July 2033; then $50.00 annually

from August 2034 to life expectancy. This cost will have to be updated to 2019 rates. The

undersigned assumes Kaiser HMO would not pay for this cost.

The undersigned will pay for a visit to Bastyr University Medical Center to see an

endocrinologist once a year for $151.00 annually through July 2033; then $30.30 annually from

August 2034 to life expectancy. This cost will have to be updated to 2019 rates. The

undersigned assumes Kaiser HMO would not pay for this cost.

The undersigned will not pay for a visit to Dr. Leslie S. Feinberg, a chiropractor who uses

NMT (neuromodulation technique) which is unproven as medical treatment. The undersigned

does not find NMT reasonable and necessary.

The undersigned will not pay for hyperbaric oxygen therapy (“HBOT”) as its use is not

reasonable and necessary for petitioner’s condition.

The undersigned will pay for blood-drawing twice a year for $300.00 annually through

July 2033 to check petitioner’s kidneys. This cost will have to be updated to 2019 rates.

The undersigned will not pay for ultraviolet irradiation of blood (“UBR”) as its use is not

reasonable and necessary for petitioner’s condition.

The undersigned will pay for mileage of $150.00 annually to see the endocrinologist,

immunologist, and Dr. Wilkinson from now to life expectancy.

The undersigned will not pay for case management is petitioner is not cognitively

damaged.

The undersigned will not pay for the drugs and other medications listed on pages 4 to 5 of

petitioner’s life care plan as Kaiser Permanente will pay for drugs through July 2033 and

Medicare Part D under the SilverScript Choice will pay for drugs from August 2034 through life

expectancy.

13

The undersigned will not pay for acupuncture as it is not reasonable or necessary for

petitioner’s condition.

The undersigned will not pay for syringes with needles and alcohol swabs as they are not

reasonable or necessary for petitioner’s condition.

The undersigned will pay for a handheld shower head at a cost of $25.00 now and every

five years to life expectancy.

The undersigned will pay for a shower chair at a cost of $41.99 now and every 10 years

to life expectancy.

The undersigned will not provide petitioner with a companion. However, the

undersigned will provide him with assistance of light housekeeping and errands of three hours

per week and assistance with snow removal, handyman services, and lawn care at an annual cost

of $4,082.52 now to life expectancy. This cost will have to be updated to 2019 rates.

III. Medicaid Lien

Petitioner requests compensation for a Medicaid Lien of $2,173.12 to Rawlings Company

and $252.77 to Washington State Healthcare Authority. Doc 186, at 5-6. Petitioner also

requests compensation for another Medicaid lien of $465.36 which Centene-Washington-

Coordinated Care (“Centene-CC”), a Medicaid plan, paid. Doc 188-2, at 1-2.

IV. Pain and Suffering

In his motion, petitioner argues that his past pain and suffering has clearly exceeded the

statutory cap since his Tdap vaccination and he continues to experience daily pain and emotional

distress. Doc 176, at 4-5. As a result, he asserts that he is entitled to the full $250,000.00 in

pain and suffering under the Vaccine Act. Id. at 5.

Based on the evidence provided in the case, the undersigned finds an award for “pain and

suffering” to be appropriate. In determining how much to award in pain and suffering for

petitioner, the undersigned notes that any amount for future pain and suffering must be adjusted

to its “net present value.” Youngblood v. Sec’y of HHS, 32 F.3d 552 (Fed. Cir. 1994). The

undersigned finds it appropriate to use a NDR of 0.50 percent per year in calculating the net present

value of the future award. The award for future pain and suffering will be calculated based upon

$75,000.00 divided over a 31-year period, utilizing a NDR of 0.50 percent per year. Therefore, the

undersigned awards petitioner $100,000.00 for past pain and suffering and $64,255.95 as net

present value of $75,000.00 for future pain and suffering.

CONCLUSION

The undersigned finds that petitioner is entitled to an award of the following damages:

14

a. Loss of earnings, including W-2 income based on respondent’s calculation subject to

the change of date as the demarcation between petitioner’s past and future damages,

employer contribution to petitioner’s 401(k) account,8 and $338,859.00 as his loss of

ownership income;

b. Past and future unreimbursable medical expenses for his entire immunologic reaction

caused by the Tdap vaccine;

c. Medicaid lien which is a compilation of the sums filed; and

d. $164,255.95 for past and future pain and suffering.

Respondent’s report regarding updated amounts and his position on reimbursement

of past health insurance premiums is due April 15, 2019.

IT IS SO ORDERED.

Dated: March 14, 2019 /s/ Laura D. Millman

Laura D. Millman

Special Master

8

Both parties agree that petitioner’s employer contributions to his 401(k) account is at five percent of

petitioner’s W-2 income. Doc 143-1, at 4 and Doc 150-2, at 3. The calculation should be consistent

with the undersigned’s ruling for W-2 income, wage growth rate, and discount rate.

15

This is a copy of a public record, reproduced as it was published. It is not legal advice, and it may not be the version a court would rely on. Check the official source before you cite it.

A word about cookies

We need a few to keep you signed in and the library working. The rest help us see which pages people use and where they get stuck. They stay off unless you say yes.